µo·s¸ÜÃD
¥´¦L

[Âà¶K] ¿Ñ±þ:¸ë§B´µ¯u¥¿¦º¦]

¿Ñ±þ:¸ë§B´µ¯u¥¿¦º¦]

³Ìªñ±NÀ¹µá¤Oªº®Ñ¡mÀù¯g--¬°¤°»ò§Ú­ÌÁÙ«÷¦º©R¦a­nª¾¹D¯u¬Û¡n(Cancer - Why we're still dying to know the
truth)¦A¥J²Óªº¾\Ū¡A¹ï³o¦ì¸ê²`°OªÌ©âµ·­éõªº¥\¤O¡B©P©µ§¹¾ãªºÆ[¹î¤Î¿W¨ìµLꪺ¤ÀªRÂk¯Ç¤Q¤À¨ØªA¡A¤]¹ï¥L¤j·O´d¡B¤jµL¬Èªººë¯«Æg¹Ä¡C



À¹µá¤O¦b®Ñ¥»²Ä¤@³¹§Y´£¥X¤@­Ó³Ì­«­nªº°ÝÃD--§Ú­Ì¨ì©³¥i§_¥´±ÑÀù¯g¡H¬ü°ê¨¾Àù¨ó·|ªº²Î­p¸ê®ÆÅã¥Ü¡AÀù¯g¬°¬ü°ê¤HªºÀY¸¹±þ¤â(¤]¬O¥xÆW¥Á²³ªº²Ä¤@¦º¦])¡F
¨C¤T¤H´N¦³¤@¤H·|±o¨ìÀù¯g¡F­Y¦¹²{¶H«ùÄòµo®i¤U¥h¡A¨ì¤U­Ó¥@¬ö¡AÀù¯gªº­P¯f²v¬O100%¡C¨Ò¦p¹L¥h¤G¤Q¦~¦º©ó¨ÅÀùªº¬ü°ê¤k©Êªº¤H¼Æ¡A´N¤w¶W¹L¨â¦¸¥@¬É¤j¾Ô
¥[Áú¾Ô¦A¥[¶V¾Ô¦º¤`¤H¼ÆªºÁ`¦X¡C¬GÀ¹µá¤O©Ò´£ªº°ÝÃD¦³¨ä­¢¤Á©Ê©M­«­n©Ê¡C¥L©Òµ¹ªºµª®×¤]«Üª½±µ--¬Oªº¡AÀù¯g¦b´X¤Q¦~«e¦­´N¦³¸Ñ¤F¡A¥u¬O¯u¬Û¤@ª½³QÁô¿f¡A
ª½¨ìºô»Úºô¸ôªºµo®i¡A³o­Óªº¸Ñµª¤~º¥º¥¬y¶Ç¶}¨Ó¡C



µM¦Ó¬ü°êªºÀù¯g¬Fµ¦¬O¦p¦ó§Î¦¨ªº©O¡H³o±o±q¥t¤@¦ì§@ªÌ¦ã¼wµØ¡D¸¯¹pªâ(Edward Griffin)©Ò¼gªº¡mµLÀù¯gªº¥@¬É¡n(World without Cancer)¤@®Ñ¬Ý¥XºÝ­Ù¡C¸¯¤ó¦b®Ñ¤¤±N¬ü°êªº²{¥NÂå¾ÇªºÂàÅÜ¡A¤ÎÂåÃľǬɹï¯e¯fªºÆ[©À­z»¡­«ÀY¡C



¸Ü»¡¤G¦¸¤j¾Ô¤§«e¡A¥þ¥@¬É³Ì¤jªº¤Æ¾Ç¤Î»sÃĤ½¥q¬°¼w°êªºªk»«(I.G.
Farben)¤½¥q¡C¥¦¤£¶È¹M¤Î¤E¤Q¤T°ê¡A¥B¹ï¦U°ê¦³­«­nªº¬F¸g¼vÅT¤O¡Fªk»«¤½¥q¤]¬O«á¨Ó´c¦W¬L¹üªº±O±þµS¤Ó¶°¤¤Àç¬r®ðªº»s³yªÌ¡C³o®a¤½¥q¦b¤G¤Q¦~¥N§Y©M
¬ü°êªº¤u·~ÃbÂ_ªÌ¬¥§Jµá°Çªº¤½¥q¦X§@¦¨¥ß¤F¤@­Ó¥þ¥@¬É³Ì¤jªº»sÃĤ½¥q¡Cª½¨ì¤µ¤Ñ¡A³o®a¤½¥q°ò¥»¤W¥H¦UºØ¦WºÙ¤Î²Õ´¡A¦b¬ü°êªº¬ì¾Ç¤Î§ÜÀù¬Fµ¦¤W§êºtµÛ·¥­«­n
ªº¨¤¦â¡C



¬¥¤ó¶°¹Îª¾¹D¬ì¾Ç¥i¥H±a¨Óªº»Ý¨D¤Î¤j¶qªºª÷¿ú§Q¯q¡C¦b¥¦­Ì©ÒÃÙ§Uªº¬ü °ê Âå®v¾Ç·|(American Medical
Association)©M¬ü°ê­¹ª«¤ÎÃĪ«ºÞ²z§½(FDA)§å­ã¤U¡A±N¤Æ¾Çª«ºÙ¬°¡uÃÄ¡v¨Ó¥Ó½Ð±M§Q¡A¨Ã´£¨Ñµ¹¸g¥Ñ¥¦­Ìªº²Õ´©Ò°V½mªºÂå®v¤Î±M®a¨Ï¥Î¡C¦b¤G
¤Q¥@¬öªì´Á¡A¨È§B¨u¡EºÖ¨Ó«ä®³(Abraham Flexner)¦b¬¥¤ó©M¥d¤º°ò(Andrew
Carnegie)ªºÁ×µ|°òª÷ÃÙ§U¤U¡A¹ï¬ü°êªºÂå¾Ç°|¶i¦æ§ï­²¡A¨Ï±oÂå¥Í¨Ì¿àÃĪ«¨ÓªvÀø¯e¯f¤Î±q¨Æ¶}µo·sÃĪ«ªº¬ã¨s¡C¦Ó¦b¬F©²³¡ªùªº­n¾©x­û¦W³æ¤¤¡A¤£Ãø
µo²{³\¦h»P¬¥¤ó¶°¹Îªº±¾¤Ä²ª¸ñ¡C¥Ñ¦¹¥iª¾¬¥¤ó¶°¹Î¹ï¬ü°ê­¹ª«¤ÎÃĪ«ºÞ²z§½©M¦U¯Åªº¬F©²³¡ªùªº¼vÅT¡A¥i»¡¬O§G½u§¹¾ã¡BÀôÀô¬Û¦©¡B¨c¤£¥i¯}¡C



¬¥¤ó¶°¹Î¥Hª÷¿ú§ïÅܤF¦Ñ¦¡ªºÂåÀø¦æ¬°¡AÂà¦Ó¨Ï¤§²{¥N¤Æ¡A²Õ´¤Æ¤Î°Ó·~¤Æ¡A¦¨¬°¥HÃĪ«ªvÀø¬°¥Dªº·í¤µÂåÃĤu·~¡C¥¦§ïµ½¤FÂå®vªº¥Í¬¡¡A¨Ï¥L­Ì±q½a¦Ó¸¨¾zªº­¦¤¤
³Â³¶¡A­¸¤WªKÀYÅܬ°°ª©Ò±o¡B°ª±Ð¨|¡B°ªªÀ·|¦a¦ìªº»ñ°Ä¡C³o¨ÇÂå¥Í¦b¬¥¤ó¶°¹Î©M¥d¤º°òªº°òª÷·|¥X¿ú©Ò«ØªºÂå¾Ç¤¤¤ß¨ü°V¡A¥L­ÌªºÃĪ«¬ã¨s¤]±o¨ì¤j¶qªº°]°ÈÃÙ
§U¡C



¦b°Ó·~±¾«Óªº¤G¤Q¥@¬ö¡A¥tÃþÀøªk©Î¬OµLªk¥Ó½Ð±M§QªºªvÀø¤èªk¡A¤£¦ý¤£¬°¥D¬yÂå¬É©Ò±µ¨ü¡AÁÙÀW³Q­¢®`¡B©Ù¶Â(¦©¥HµL¬ì¾ÇÃÒ¾Úªº¤j´U)©MÁô¿f¡F¤[¦Ó¤[¤§¡AªÀ·|
¤j²³¤]±µ¨ü¥D¬yÂå¾Ç¤Î¨ä¬ãµoªº·sÃĪ«¬O§ÜÀù°ß¤@§Q¾¹ªº«äºû¡C¦]¦¹¤W¥@¬öªº«e¥b¸­¡A¥H¦Ê¸U¬°³æ¦ìªºª÷¿ú¤j¶qª`¤J°ê»Ú¯ÅªºÃĪ«¬ã¨s¡A´Á±æ§ä¨ì¦³®ÄªºÃĪ«¨Ó¹ïªv
¦UºØ¤£¦PªºÀù¯g¡C¥Ñ©ó¨S¦³¤@ºØ©Ò¿×ªº¡w©_Âݪº¤l¼u¡vÀøªk¬O¤@Ãà¥i¦¨ªº¡A¥@¬É¦U¦aªºÂå¾Ç¤¤¤ß´N¤£Â_¦a¹ï¯f¤H¶i¦æ·sÃĤΩñ®g½uªº¹êÅç¡C



§Y¨Ï¦b¤µ¤é¡A³o¨Ç¤ÆÀø¤Î©ñ®g½uªvÀø¤wÃÒ©ú¬OµLªkªv¡±`¨£ªºÀù¯g¡AÂå®v­ÌÁÙ¬OÄ~Äò¨Ï¥Î¥¦­Ì¡C³ø¯È±`¦³§ÜÀù·sÃĦ¨¥\µo©ú¡A©Î§ÜÀù¦³­«¤j¬ð¯}µ¥ªº·s»D¥X²{¡A¦ý²{
¥NÂå¾Ç¯u¥¿¦aªvÀø¦nÀù¯g¤F¶Ü¡H¦³¨ÇÂå®v¤£¸T¶}©lÃhºÃ¤ÆÀøªº¬r©Ê¤Ï¦Ó¬O³y¦¨Àù¯g¯f¤Hªº¦º¤`¥D¦]¡C1985¦~¡A«¢¦ò¤j¾Ç·L¥Íª«±Ð±Â¬ù¿«¡E³Í®¦´µ(John
Cairns)¦b¬ì¾Çªº¬ü°ê¤H(Scientific American)Âø»xµoªíµû½×»¡¡G¡K¡u¤ÆÀø¯à§_ªv¡¥ô¦ó¤@ºØ±`¨£ªºÀù¯gÁÙ¦³«ÝÃÒ¹ê¡C¡v



¦³¨Ç¸~½FÂå®v¬O·|§i¶D¯f¤H¨S¦³ÃÒ¾ÚÅã¥Ü¤ÆÀø¦³®Ä¡F¦³¨Ç«h³Q¬ì¬ã³ø§i»~¾É¤ÆÀøµLªk«OÃÒªº¼ÖÆ[¡F¦³¨Ç§ó¬°¤Fª÷¿úªº²z¥Ñ¦Ó¶}¨ã¤ÆÀø³æ¡C¦]¬°¶}¨ã¤ÆÀø³æ¤ñµ¹¯f¤H¼¾¼¢ÁÙÁȪº¦h¡CÀ¹µá¤O§óª½¨¥¡A¦b¤C¦Ê»õ¬ü¤¸ªº¤ÆÀø¤u·~ªº¤µ¤Ñ¡A¨Ì¾aÀù¯g°Q¥Í¬¡ªº¤H¼Æ¤ñ¦º©óÀù¯gªº¤HÁÙ¦h¡C



À¹¤ó¦b®Ñ¤¤Á|¥X³\¦h¥D¬yÂå®v¤£Â_¦a¥X¨Óµoªí¤ÆÀøµL®Äªº¨¥½×¡C¤ñ¦p¡G1992¦~¡A¬rª«¾Ç®a¤sÙç¡E¦ã´¶´µ©Z(Samuel
Epstein)Âå®v»P¤T¦ì«e¬ü°êÁp¨¹©x­û¦bµØ©²¦@¼g¤F¤@¥÷Án©ú¡A³o¥÷Án©ú¸g¥Ñ64¦ì¦b¤½¦@½Ã¥Í¡BÀù¯g¹w¨¾¤Î¯e¯f¹w¨¾»â°ìÄÝ©ó»â¾É¦a¦ìªº±M®a­I®Ñ¡CÁn©ú«ü
¥X¡G¡u§Ú­Ì«ÜÃö¤Á°]·½¶¯«pªºÀù¯g·~¬É¡A¥ç§Y°ê®aÀù¯g¾÷ºc(National Cancer
Institute)¡B¬ü°ê¨¾Àù¨ó·|¤Î¤G¤Q´X®a§¹µ½ªºÀù¯gªvÀø¤¤¤ßµ¥¡A¥H¤£Â_ªº¡y¾Ô³ÓÀù¯g¡zªº¥D±i»~¾É¤Î°g´b¬ü°ê¤j²³¤Î°ê·|¡C¦p¤µÀù¯g¨C¦~¹Ü¨«¶W¹L¤­¤Q¸U
¤H¡A¨C¤T¦ì´N¦³¤@¦ì¬ü°ê¤H±o¨ìÀù¯g¡A¨C¥|¦ìÀù¯g¯f¤H´N¦³¤@¦ì¦º©ó¥¦¡C¹L¥h¤Q¦~¡A¤­¦Ê¸U¬ü°ê¤H¦º©óÀù¯g¡A¦Ó¶V¨Ó¶V¦hªºÃÒ¾ÚÅã¥Ü¤j³¡¤À³o¨Ç¦º¤`¬O¥i¥HÁקK
ªº¡K¡K



¦ÓÀù¯g·~¬É¤Î¥D­nªº»sÃĤ½¥q°Ê¤£°Ê´Nµoªí²@µLÃÒ¾ÚªºÁn©ú»¡¡AªvÀøÀù¯g¦³­«¤j¶i¨B©Î¡uªv¡¡vÀù¯gªº®ø®§¡C³oºØÁn©ú¥u¬O°ò©ó¸~½F²Õ´ªì´ÁªºÁY¤p¡A¦Ó«D©µªø¯f¤Hªº¦s¬¡®É¶¡¡A¦Ó¥B¯f¤H¥Í¬¡ªº«~½è³Q°ª¬r©ÊªºªvÀøÄY­«ºR·´«h§¹¥þ¤£¨ü­«µø¡C¡v



1986¦~¡A³Á¦Nº¸Àù¯g¤¤¤ß(McGill Cancer Center)ªº¬ì¾Ç®a­Ì¹ï¤@¦Ê¤@¤Q¤K¦ìªvÀø«D¤p²Ó­MªÍÀù(non-small-cell
lung
cancer)ªºÂå®v¶i¦æ°Ý¨÷½Õ¬d¡Aµo²{¶W¹L¥|¤À¤§¤TªºÂå®v¼x¨D¯f¤H¶i¦æªÍÀù°ª¬r©Êªº·sÃĹêÅç¡C¥L­ÌÁÙ³Q°Ý¨ì¡A°²³]¬O¥L­Ì¦Û¤v±o¨ìÀù¯g¡A·|¥Î·í®É¥L­Ì¿ï¾Ü
ªº¤»ºØ·sÃĤ¤ªº­þ¤@ºØªvÀø¡H¦b¤C¤Q¤E¦ì¦^µª¤¤¦³¤»¤Q¥|¦ì»¡¡A¥ô¦ó§t¦³¤@ºØ·¥¬rªºCisplatin¤ÆÀø·sÃĪ«¥L­Ì³£¤£·|¿ï¥Î¡C¤­¤Q¤K¦ìÂå®vµo²{©Ò¦³ªº·sÃÄ
³£µL®Ä¡A­ì¦]¬O¤ÆÀøªºµL®ÄªG¤ÎÃø¥H±µ¨üªº°ª¬r©Ê¡C



¼w°êªºÁ{§ÉÀù¯g¥Íª«²Î­p¾Ç®aÀu·ç³\¡E·R³ÕÂå®v(Ulrich
Abel)¦b1990¦~±d´_Âø»x´£¥X¡m¶i®i«¬¤W¥Ö²Ó­MÀù¯gªº¤Æ¾ÇÀøªk¡n(Chemotherapy of Advanced Epithelial
Cancer)ªº¬ã¨s¤ß±o¡A¥L§NÀR¦Ó¤£°¾»á¦a¤ÀªR¹L¥h¤Q¦~ªºÂå¾Ç³ø§i¡Aµo²{³Ì±`¨£ªº¤W¥Ö²Ó­MÀù¯g¡A¦pªÍÀù¡B¨ÅÀù¡BÄáÅ@Àù¡Bª½¸zÀùµ¥ªº¤ÆÀø«Ü¤Ö¦³¦¨¥\ªº¡C¦Ó
¥þ¥@¬É¨C¦~¦³¤@¦Ê¦h¸U¤H¦º©óÀù¯g¡A¥L­Ì¤j¦h¼Æ´¿±µ¨ü¹L¤ÆÀø¡A¨Ï¥Î¤ÆÀøªº¦¸¼Æ¤]¶V¨Ó¶V¦h¡C·R³ÕÁÙ¹ï´X¦Ê¦ìÂå®v°µ°Ý¨÷½Õ¬d¡Aµo²{¡G¡u³\¦hÂå¥Í­Ó¤H¹ïÀù¯gªºÆ[
ÂI¡A»P¤j²³©Ò»{ª¾ªº¸ê°T¦³¦p¤ÑÄ[¦a§Oªº¬Û¤Ï¡C¡v¡u¦pªG¥L­Ì¦Û¤v±o¤FÀù¯g¡A¥L­Ì¤£·|°µ¤ÆÀø¡I§Y¨ÏÀù²Ó­M¹ï¤ÆÀø¦³¤ÏÀ³¡A¦ý¬O¸~½F§½³¡©Î§¹¥þªºÁY¤p¡A¨Ã¤£·|©µªø
¯f¤Hªº¦s¬¡²v¡C¡v¡u¦³®É­ÔÀù¯g´_µo¤Ï¦Ó§ó¥[¸v­h¡A¦]¬°¤ÆÀø§Uªø§ÜÀøÀù²Ó­Mªº¥Í¦¨¡C¡v



·R³ÕÂå¥Í±N¤ÆÀø¯f¤H¦b¦s¬¡²v§ïµ½¤è­±¡A¨Ì¤£¦PªºÀù¯g»P¥¼¨ü¤ÆÀøªº¯f¤H°µ¤ñ¸û¡C²Î­pµo²{¡G



µ²ª½¸zÀù¡GµLÃÒ¾ÚÅã¥Ü¤ÆÀø¯f¤H¦s¬¡²vÀò§ïµ½¡C



­GÀù¡GµL©úÅãÃÒ¾Ú¡C



¯ØŦÀù¡G¦s¬¡²v§¹¥þµL®Ä¡F¥¼±µ¨ü¤ÆÀøªº¯f¤H¬¡±o¸û¤[¡C



»H¯ÖÀù¡G¥¼°µÁ{§É¹êÅç¡C



¨ÅÀù¡GµLª½±µÃÒ¾ÚÅã¥Ü¤ÆÀø©µªø¦s¬¡²v¡A¤ÆÀø¤§¨Ï¥Î¦³¹D¼w¤WªººÃ°Ý(¤j¦h¼Æ¨ÅÀù±wªÌ¦b¤â³N«e«á³£µ¹¤©¤ÆÀø)¡C



§Z±_Àù¡GµLª½±µÃÒ¾Ú¡C



¤l®c¤Î¤l®cÀVÀù¡G¦s¬¡²v¥¼Àò§ïµ½¡C



ÀYÀV³¡Àù¡G¦s¬¡²v¥¼±o¨ì§ïµ½¡A¶È¦³¹s¬PªºÁY¤p¡C



¤@¦ìªk°êªº¸~½F±M®a¬d²z¡E°¨¤h(Dr. Charles
Mathe)¬Æ¦Ü»¡¡G¡u§Ú¦pªG±o¤FÀù¯g¡A§Úµ´¹ï¤£·|¨ìÀù¯gªvÀø¤¤¤ß¥h¡A±wªÌÂ÷³o¨Ç¤¤¤ß¶V»·¡A¶V¦³¥Í¦sªº¾÷·|¡C¡v¥[¦{¤j¾Çªº«¢¤B¡Eã´µ(Dr.
Hardin Jones)¤ÀªR¤F´X¤Q¦~¨ÓÀù¯g¯f¤Hªº¦s¬¡²v²Î­p«á»¡¡G¡u¡KÀù¯g¯f¤H¥i¯àÁÙ¬O¤£­nªvÀøªº¦n¡C¡v¹³³o¼ËªºÀù¯gÂå®vªº¨£ÃÒ¦bÀ¹¤ó®Ñ¤¤¤ñ¤ñ¬Ò¬O¡A
¨º»ò Âå®v¬°¤°»òÁÙ­n¹ï¥L­Ì¤]§ô¤âµLµ¦ªº¯f¯g¦V¯f¤H»¡¥i¥HªvÀø©O¡H



¨É¦³¡y¤ß²z¾Ç¬Éªº·R¦]´µ©Z¡z¶®¸¹ªºªÖ®¦¡E«Âº¸³Õ(Ken Wilber)¦b¡m®¦Ãd»P«i®ð¡n(Grace and Grit¡A ±i
¦Ñ®v¤å¤Æ¥Xª©)¤¤¡A°O­z¥Lªº©d¤l¿©Àùªº¹Lµ{¡C¥L´£¨ì¤@¦ì¦n¤Í¿©±w¤F¥½´ÁÀù¯g¡A¦oªºÂå¥Í«Øij±µ¨ü¥t¤@ºØ«D±`±j¯Pªº¤ÆÀø¡A¦pªG·ÓÂå¥Íªº¸Ü°µ¡AÀ³¸ÓÁÙ¥i¥H¬¡¤Q¤G
­Ó¤ë¡C¦o´£¥X¤F¤@­Ó°ÝÃD¡G¡u¦pªG§Ú¤£±µ¨ü¤ÆÀø¡AÁٯଡ¦h¤[¡H¡vÂå¥Í¦^µª¡G¡u¤Q¥|­Ó¤ë¡C¡v¦A«×«Øij¦o±Ä¥Î¤ÆÀø¡C®Ñ¤¤¤S´£¨ì¤@¦ìÀù¯gªvÀøÅv«Â¼g¤F¤@¥»«D±`¨ü­«
µøªº®Ñ¡m¥ô©Êªº²Ó­M¡n(The Wayward
Cell)¡C¥Lªá¤F³\¦h½g´T»¡©ú¤ÆÀø¬°¤°»òµL®Ä¡A±µµÛ¤S»¡©ú§Y¨Ï¦p¦¹¡A¤ÆÀø¤´µM¸Ó³Q±Ä¥Î¡A¡u¦]¬°¤ÆÀø¯àÅý¯f¤Hºû«ù¥¿½TªºÂåÀø¤è¦V¡C¡vªÖ®¦ªºµû»y¡G¡u¦Ñ¹ê
»¡¡A¥¦¤]ªýê¤F¯f¤H´M¨D¨ä¥LªºªvÀø³~®|¡K³o®Ú¥»¤£¬O¦bªvÀø¯e¯f¡A³o¬O¦bªvÀø¤ß¯f--Âå¥Í¥ø¹Ï±±¨î¯f¤H¹ï¯e¯fªº²z¸Ñ¥H¤Î¨ä¥i¯à´M¨DªºªvÀøºØÃþ¡C¬YºØªvÀø¤]³\
¹ï¯e¯fµL®Ä¡A¦ý¹ï¤ß¯f«o¦³®Ä¡A¦]¬°¥¦¥i¥H¤Þ¾É¯f¤HÅ¥«H¬Y­ÓÅv«Â©M±µ¨ü¬YºØÂåÀø¡C¡v



ªÖ®¦¦b®Ñ¤¤»¡¸~½FÂå®v¨Ã«D¥ø¹Ï´c·N¾ÞÁa¯f¤H¡A¤]«D¨è·N±»¹¢¥L­Ìªº¦³­­ªº§Þ¯à¡A¥L­Ì¦b¯f¤H¼ö¤Áªº´Á±æ¤U¡A¦P¼Ë·P¨ìµL§U¡C¦]¬°ÂåÀø¹ïÀù¯gµL®Ä¡A©Ò¥HÂå®v³Q­¢§ê
ºt¦w¼¢¯f¤Hªº¨¤¦â¡AÁöµM³oÃþ¨¤¦â¬O©v±Ð®aªº±Mªø¡A¹ïÂå®v¦Ó¨¥¬O¤í¯Ê°V½mªº¡C¦ý¬O¦b¯f¤Hªº²´¤¤¡AÂå¥Í½T¹ê¬O¦a¦ì±R°ªªºªª®v¡C



¥D¬yÂå®v¦h¥b¹ï¥tÃþÀøªk¤£¼ô±x¡A¥L­Ìªº¥Í¬¡«D±`¦£¸L¡A¥H¦Ü©ó¥L­Ì±o¨Ì¿àÂå¾Ç¬ã¨s©Î¹êÅç²³ø¬°°T®§¨Ó·½¡F¦Ó³o¨Ç²³ø¤S¦h¬°¤Ï¹ï¥tÃþÀøªkªº²Õ´¾÷ºc(¤ñ¦pÃļt
©ÎÀù¯gÂå¾Ç¤¤¤ß)©Ò·Ç³Æ¡C¦]¬°¤@¦ìÀù¯g¯f¤H¹ïÀù¯gÂå°|©Î¤¤¤ß¨Ó»¡¬O¤@­Ó§Q¼í¤¤¤ß(profit
center)¡A¥D¬yªºÀù¯gªvÀø¦b¤µ¤éªº¬ü°ê®Ú²`¸¦©Tªº·Ç«hªº­ì¦]¡A´N¦b©ó¥¦­Ì¥i¥HÅýÂå°|Áȱo³Ì¦h¡A¦Ó¥B«OÀIÄ@·N¥I¿ú¡C©Ò¥H²{¦æªº¬ü°êÀù¯gÂåÀø¬Fµ¦¡A·|Ä~
Äò±»¹¢¨Æ¹ê¡A°£«D§A¦Û¤v±q¥L­Ìªº¯«¸Ü¤¤¿ô®©¡C



¨º»ò¤µ¤éªºÀù¯g¯f¤H¨ì©³¦³¤°»ò¾÷·|©O¡H¦¹§Yº¥º¥¶i¤J¥»®Ñªº¥DÃD¤F¡C



¸Ü»¡1950¦~¥N¡A¤@¦ì¥Í¤Æ¾Ç®a¤p®¦´µ¯S¡E§J¹p¥¬´µ(Ernst T. Krebs, Jr.)¤ÀÂ÷¥X¤@­Ó·sªººû¥Í¯ÀB17(Vitamin
B17)¡A¤SºÙ¬°¡y¤O¦Ó¨ô¡z(Laetrile)¡B¡yªü¦Ì¹FÆF¡z(amygdalin)¡C¥L·í®É¤£²M·¡¦Û¤v±È°_¤F¤°»ò¼Ëªºº§º¬¡AÁöµM¦Ü¤µ³\¦h¤H¤´¬Û«H§J¹p
¥¬´µ§ä¨ì¤FÀù¯gªºÀøªk¡FµM¦Ó¸ó°ê»Úªº¤j»sÃļt¦]¬°µLªk¥Ó½Ð±M§Q©ÎÃbÂ_ºû¥Í¯ÀB17ªº¨Ï¥Î¡A¬G¦Ó¹ïVitB17µo°_¤FªÅ«eªº´c¬r§ðÀ»«Å¶Ç¡A§Y¨Ï¨Æ¹êÃÒ©ú¥¦¹ï
©ó¦UºØÀù¯g¦³Àø®Ä¡C



§J¹p¥¬´µ©M¥Lªº¤÷¿Ë¤]¬O±Nºû¥Í¯ÀB15(Pangamic
acid)À³¥Î¦bÂå¾Ç¤Wªº¥ýÅX¡C¥L¦b¤G¦¸¥@¬É¤j¾Ô«eªº¬ã¨s¡A¥D­n¶°¤¤¦b»Ã¯À¤Î¨ä¦bÀù¯gªvÀø¤WªºÀ³¥Îµ¥¤è­±ªºª¾ÃÑ¡A³o¨Ç»Ã¯À¥]¬A¡G»ñ±ù»Ã¯À
(bromelain)¡Achymotrypsin¡A©M¤ì¥Ê»Ã¯À(papain)¡C¤÷¤l¨â¦ì¦Ü¤µ³Q¤´¤½»{¬°ºû¥Í¯ÀB17(VitB17)¦bÀù¯gªvÀø¾÷Âà¤è
­±ªº¥ýÅX¡Cºû¥Í¯À
B17¬O¤@ºØ¤ô·»©Ê¡BµL¬r©ÊªºÁޤƦXª«¡A¦s¦b©ó¦ÛµM¬É¬ù800ºØªº´Óª«¤¤¡A³\¦hºØ¥i¥H­¹¥Î¡C§tÂ×´IVitB17ªº¨Ó·½¡A³Ì±`¨£©ó«D¬a¾ïÄݤôªGªººØ¤l¤¤¡A
¦p¡GÄå®ç¡Bªo®ç¡B®ç¤l¡B§õ¤l¤ÎÄ«ªGµ¥¡A¦Ó¥H§ö¤l(apricot)ªººØ¤l§t¶q³ÌÂסA¬ù¦³¦Ê¤À¤§2¦Ü2.5¡C



®Ú¾Ú¸¯¹pªâ´µ¡mµLÀù¯gªº¥@¬É¡n¤@®Ñ¡A§J¹p¥¬´µ¬ã¨s¤§¯ßµ¸·¹·½¦Û¤G¤Q¥@¬öªì¸­¡A·R¤B³ù¤j¾Ç±Ð±Â¬ù¿«¡E²¦º¸¼w(John
Beard)´£¥XÀù¯gªºÀç¾i²Ó­M²y(trophoblast)±À½×¡C²¦¤óªº¬ã¨sµo²{Ãh¥¥ªì´Áªº­ì©l­F­L²Ó­M(pre-embryonic
cells)¥ç§YÀç¾i²Ó­M²y»P´c©Ê¸~½F²Ó­M¨S¦³°Ï§O¡CÀç¾i²y²Ó­M¬°­F­L¦¨ªø©Ò¥²»Ýªº¡A¦ý¬O¦bÃh¥¥´Áªº²Ä56¤Ñ¡A­L¨àªº·s¯ØŦ¶}©l¤Àªc
chymotrypsina»Ã¯À¡A±q¨º®É¤§«á¡AÀç¾i²Ó­M²yªº¼W¥Í´N³Qªý¤î¡C¸¯¤ó¼g¹D¡G¡uÀç¾i²Ó­M²y¦bÃh¥¥ªì´Á½T¹ê¨ã¦³Àù²Ó­Mªº¯S¼x¡A¦]¬°¥¦·|«Ü§Ö³t¦a¼W¥Í
¤Î½¯©µ¡A³Ì«á¥¦µÛ§É©ó¤l®c¾À¤W§Î¦¨­L½L¡AÅý­F­L¥i¥H±o¨ì¥ÀÅ骺«OÅ@©MÀç¾i¡C¡v



Àç¾i²Ó­M²y¬O¥t¤@ºØ²Ó­M¸g¥Ñ¤@³s¦êªº¨BÆJ©Ò§Î¦¨ªº¡A¸¯¤ó±N¤§Â²¤Æ¬°¡y§¹¥þ¥Í©R¡z²Ó­M(total life
cell)(¦³ÂI¹³²{¦b³Ì¼öªùªº·F²Ó­M)¡A¥¦¥i¥H¤À¤Æ¬°¥ô¦ó¤@ºØ¾¹©x©Î²Õ´¡A¤D¦Ü¤@­Ó§¹¾ãªº­F­L¡C·í§¹¥þ¥Í©R²Ó­M³Q¨k¤k¬Ò¦³ªº°Ê±¡¿E¯À±Òµo¦Ó¶}©l»s³yÀç¾i
²y²Ó­M®É¡A¦³¨âºØµ²ªG¥i¯àµo¥Í¡C²Ä¤@¡A¦pªG¬O¦bÃh¥¥ªº±¡ªp¤U¡Aµ²ªG´N·|§Î¦¨­L½L¤ÎÂÀ±a¡F²Ä¤G¡A¦pªGÀç¾i²y²Ó­M¬O¦b­×¸Éªº±¡ªp¤U³Q±Ò°Ê¡Aµ²ªG´N¬OÀù²Ó­Mªº§Î
¦¨¡C¸¯¤ó¸É¥R¡G¡u§ó¥¿½Tªº»¡ªkÀ³¸Ó¬O¡A¦pªG²Ó­M­×´_¤uµ{¨S¦³µ²§ôªº¸Ü¡A´N§Î¦¨Àù¡C¡v



Àç¾i²Ó­M²y¤Àªcªºµ³¤ò¨ë¿E¥Í´Þ¿E¯À(chorionic gonadotrophin -
HCG)¡A¥i¥H¦Û§¿²G¤¤´ú¥X¨Ó¡A·Ç½T«×92%¡C°²³]ÀËÅç§e¶§©Êªº¸Ü¡A¸¯¤ó»¡¡G¡u­Y¬O¤k©Ê¡A¦o¦pªG¤£¬OÃh¥¥¡A´N¬O¿©Àù¡F¦pªG¬O¨k©Êªº¸Ü¡A¥u¦³¤@ºØ¥i¯à-
Àù¡C¡vµM¦ÓÂå¾Ç¬É©úª¾¦¹ÀËÅçªk²©ö«o±ó¤§¤£¥Î¡A¦Ó±Ä¥Î¦MÀI©Ê°ªªº¬ï¨ë¤â³N¡A³y¦¨¬Y¨ÇÀù²Ó­M¦]¦ÓÂX´²¨ì¥þ¨­¡C

§J¹p¥¬´µ¦Û§öªGºØ¤¯¤ÀÂ÷¥Xºû¥Í¯ÀB17¡A±N¤§¦X¦¨µ²´¹¥H¨Ñ¤HÅé¨Ï¥Î¡A¨Ã©R¦W¬°¡u§Q¦Ó¨ô¡v¡C¦¹¤Æ¦Xª«¬O¥Ñ¤@¤À¤lÙæ¤Æ²B(hydrogen
cyanide)µ²¦X¤@¤À¤l¨ã¤îµh§@¥Îªº­f¤AîÇ(benzadehyde)¥[¨â¤À¤l¸²µå¿}©Ò§Î¦¨ªº¡CÁöµM«e¨âªÌ¤À¶}¨Óªº¬r©Ê«Ü±j¡A¦ý¬O¥¦­Ìµ²¦X¦b
VitB17ªº¤À¤lùØ«o¤Q¤Àí©w¥BµL¬r©Ê¡C§J¤óµo²{¡A­n±N¨âªÌµ²¦XÁ䥴¶}¡A¥u¦³¤@ºØ¥sbeta-glucosidaseªº¸²µå¿}»Ã¯À¡F³oºØ»Ã¯ÀÁöµM¤À¥¬©ó
¤HÅé¡A¦ý¬O¦b¸~½F³B«o¬O§t¶q¯S§O°ª¡C©Ò¥HÀù²Ó­M©Ò¤Àªcªºbeta-glucosidase»Ã¯À¤@¥¹¥´¯}¤FVitB17ªºµ²¦XÁä¡AÄÀ©ñ¥XÙæ¤Æ²B¤Î­f¤AîÇ¡A¨â
ªÌ¬r¤À¤l¥[¦b¤@°_¬r©Ê§ó¬O¶W±j¡AÀù²Ó­M´N¦º¦b¥¦­Ì¦Û¤v¿ï¾ÜªºVitB17¤âùØ¡C(¥¼§¹«ÝÄò)

TOP

·P°Êªº¤p«~,´Á±æ¨C­Ó¤H³£¦³©¯ºÖªº

TOP

«D±`·PÁ¤j¤jªº¤À¨É.

TOP

µo·s¸ÜÃD